|
1.
|
|
15 p, 1.9 MB |
In silico Approach for Validating and Unveiling New Applications for Prognostic Biomarkers of Endometrial Cancer
/
Coll de la Rubia, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martinez-Garcia, Elena (Luxembourg Institute of Health) ;
Dittmar, Gunnar (Luxembourg Institute of Health) ;
Nazarov, Petr V. (Luxembourg Institute of Health) ;
Bebia, Vicente (Hospital Universitari Vall d'Hebron) ;
Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Endometrial cancer (EC) mortality is directly associated with the presence of poor prognostic factors. Molecular prognostic factors have been identified, but none are used in clinical practice due to lack of validation studies. [...]
2021 -  10.3390/cancers13205052
Cancers, Vol. 13 (october 2021)
|
|
|
2.
|
|
22 p, 3.0 MB |
Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool
/
Villafranca-Magdalena, Beatriz (Universitat Autònoma de Barcelona) ;
Masferrer-Ferragutcasas, Carina (Universitat Autònoma de Barcelona) ;
López-Gil, Carlos (Universitat Autònoma de Barcelona) ;
Coll de la Rubia, Eva (Universitat Autònoma de Barcelona) ;
Rebull, Marta (Universitat Autònoma de Barcelona) ;
Parra, Genis (Centre for Genomic Regulation (Barcelona, Catalunya)) ;
García, Ángel (Hospital Universitari Vall d'Hebron) ;
Reques, Armando (Hospital Universitari Vall d'Hebron) ;
Cabrera Díaz, Silvia (Vall d'Hebron Institut d'Oncologia) ;
Colás Ortega, Eva (Universitat Autònoma de Barcelona) ;
Gil-Moreno, Antonio 1965- (Vall d'Hebron Institut d'Oncologia) ;
Moiola, Cristian Pablo (Universitat Autònoma de Barcelona)
Endometrial cancer (EC) is the second most frequent gynecological cancer worldwide. Although improvements in EC classification have enabled an accurate establishment of disease prognosis, women with a high-risk or recurrent EC face a dramatic situation due to limited further treatment options. [...]
2022 - 10.3390/ijms23116266
International journal of molecular sciences, Vol. 23 (june 2022)
|
|
|
3.
|
|
12 p, 886.3 KB |
Lymphovascular Space Invasion in Early-Stage Endometrial Cancer (LySEC) : Patterns of Recurrence and Predictors. A Multicentre Retrospective Cohort Study of the Spain Gynecologic Oncology Group
/
Oliver-Perez, M. Reyes (Hospital Universitario 12 de Octubre (Madrid)) ;
Padilla-Iserte, Pablo (Hospital Universitari i Politècnic La Fe (València)) ;
Arencibia-Sanchez, Octavio (Department of Gynecologic Oncology, University Hospital Materno-Infantil de Canarias) ;
Martin-Arriscado, Cristina (Hospital Universitario 12 de Octubre (Madrid)) ;
Muruzabal, Juan Carlos (Department of Gynecologic Oncology, Complejo Hospitalario de Navarra) ;
Díaz-Feijoo, Berta (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Coronado, Pluvio (Complutense University Madrid) ;
Martín-Salamanca, M. Belen (Department of Gynecology, Hospital Universitario de Getafe) ;
Pantoja-Garrido, Manuel (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ;
Marcos-Sanmartin, Josefa (Institute for Health and Biomedical Research) ;
Cabezas-López, Elena (Department of Gynecologic Oncology, University Hospital Ramón y Cajal) ;
Lorenzo, Cristina (Department of Obstetrics and Gynecology, Hospital Nuestra Señora de la Calendaria) ;
Beric, Duska (Department of Obstetrics and Gynecology, Hospital Universitario de Torrevieja) ;
Rodriguez-Hernandez, Jose Ramon (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ;
Roldan-Rivas, Fernando (Department of Obstetrics and Gynaecology, Clinico Lozano Blesa Hospita) ;
Gilabert-Estelles, Juan (Department of Pediatrics, Obstetrics and Gynecology, University General Hospital of Valencia) ;
Sanchez, Lourdes (Department of Gynecology and Obstetrics, University General Hospital of Ciudad Real) ;
Laseca-Modrego, Maria (Department of Gynecologic Oncology, University Hospital Materno-Infantil de Canarias) ;
Tauste-Rubio, Carmen (Department of Gynecologic Oncology, Complejo Hospitalario de Navarra) ;
Gil-Ibañez, Blanca (Hospital Universitario 12 de Octubre (Madrid)) ;
Tejerizo-Garcia, Alvaro (Hospital Universitario 12 de Octubre (Madrid)) ;
Universitat Autònoma de Barcelona
In patients with early-stage endometrioid endometrial cancer, the presence of lymph vascular space involvement (LVSI) correlates with nodal metastases, shorter disease-free survival and overall survival. [...]
2023 - 10.3390/cancers15092612
Cancers, Vol. 15 (may 2023)
|
|
|
4.
|
|
10 p, 564.4 KB |
Accuracy and Survival Outcomes after National Implementation of Sentinel Lymph Node Biopsy in Early Stage Endometrial Cancer
/
Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron) ;
Gómez-Hidalgo, Natalia R (Hospital Universitari Vall d'Hebron) ;
Bebia, Vicente (Hospital Universitari Vall d'Hebron) ;
Fernández-González, Sergi (Hospital Universitari de Bellvitge) ;
Fusté, Pere (Hospital Clínic i Provincial de Barcelona) ;
Martínez, Sergio (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Sentinel lymph node (SLN) biopsy has recently been accepted to evaluate nodal status in endometrial cancer at early stage, which is key to tailoring adjuvant treatments. Our aim was to evaluate the national implementation of SLN biopsy in terms of accuracy to detect nodal disease in a clinical setting and oncologic outcomes according to the volume of nodal disease. [...]
Springer New York, 2023 - 10.1245/s10434-023-14068-0
Annals of Surgical Oncology
|
|
|
5.
|
|
17 p, 2.5 MB |
Cervical Fluids Are a Source of Protein Biomarkers for Early, Non-Invasive Endometrial Cancer Diagnosis
/
Martinez-Garcia, Elena (Luxembourg Institute of Health) ;
Coll de la Rubia, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lesur, Antoine (Luxembourg Institute of Health) ;
Dittmar, Gunnar (University of Luxembourge) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron) ;
Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Abnormal uterine bleeding (AUB) is the main symptom of endometrial cancer (EC), but it is highly nonspecific. This represents a huge burden for women's health, since all women presenting with bleeding will undergo sequential invasive tests, avoidable in 90-95% of those women who do not have EC. [...]
2023 - 10.3390/cancers15030911
Cancers, Vol. 15 (january 2023)
|
|
|
6.
|
|
264 p, 18.1 MB |
The Sentinel Lymph Node Mapping in Endometrial Carcinoma : "Past, Present and Future"
/
Rodríguez Gómez-Hidalgo, Natalia ;
Gil-Moreno, Antonio, 1965-, dir. ;
Pérez-Benavente, Assumpció, dir. ;
Cabrera Díaz, Silvia, dir.
Objectiu: El tractament estàndard per al càncer d'endometri és la histerectomía, salpingooforectomía bilateral amb o sense linfadenectomía (según factors de risc uterino). Una de les possibles complicacions documentades de la linfadenectomía és el desenvolupament de linfedema de les extremitats inferiors. [...]
Objetivo: El tratamiento estándar para el cáncer de endometrio es la histerectomía, salpingooforectomía bilateral con o sin linfadenectomía (según factores de riesgo uterino). Una de las posibles complicaciones documentadas de la linfadenectomía es el desarrollo de linfedema de las extremidades inferiores. [...]
Objective: The treatment for endometrial cancer is an hysterectomy and bilateral salpingo-oophorectomy with or without lymphadenectomy (depending on uterine risk factors). One of the documented complications of lymphadenectomy is the development of lymphedema of the lower extremities. [...]
2022
|
|
|
7.
|
|
|
Shaping endometrial cancer diagnosis via the identification of protein biomarkers in gynecological fluids
/
Coll de la Rubia, Eva ;
Gil-Moreno, Antonio, 1965-, dir. ;
Colás Ortega, Eva, dir. ;
Cabrera Díaz, Silvia, dir. ;
Comella i Carnicé, Joan Xavier, 1963-, dir.
El càncer d'endometri (CE) és el sisè tumor més comú en dones a tot el món, amb 417. 367 casos nous i 97. 370 morts el 2020. El diagnòstic precoç del CE s'associa amb el 95% de la taxa de supervivència als 5 anys, mentre que el diagnòstic avançat la redueix al 17%. [...]
El cáncer de endometrio (CE) es el sexto tumor más común en mujeres a nivel mundial, con 417. 367 nuevos casos y 97. 370 muertes en 2020. El diagnóstico temprano del CE se asocia con el 95% de la tasa de supervivencia a los 5 años, mientras que el diagnóstico avanzado la reduce hasta el 17%. [...]
Endometrial cancer (EC) is the sixth most common tumor in women worldwide, with 417,367 new cases and 97,370 deaths in 2020. Early diagnosis of EC is associated with 95% of 5-year survival rate, while advanced diagnosis drops the survival rate down to 17%. [...]
2022
|
|
|
8.
|
|
13 p, 2.0 MB |
Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis
/
Altadill, Tatiana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Dowdy, Tyrone M. (Georgetown University Medical Center) ;
Gill, Kirandeep (Georgetown University Medical Center) ;
Reques, Armando (Hospital Universitari Vall d'Hebron) ;
Menon, Smrithi S. (Georgetown University Medical Center) ;
Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lopez-Gil, Carlos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Coll de la Rubia, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Matias-Guiu, Xavier (Institut d'Investigació Biomèdica de Bellvitge) ;
Cabrera Díaz, Silvia (Vall d'Hebron Institut d'Oncologia) ;
Garcia, Angel (Hospital Universitari Vall d'Hebron) ;
Reventos, Jaume (Universitat Internacional de Catalunya) ;
Byers, Stephen W. (Georgetown-Lombardi Comprehensive Cancer Center) ;
Gil-Moreno, Antonio 1965- (Vall d'Hebron Institut d'Oncologia) ;
Cheema, Amrita K. (Georgetown-Lombardi Comprehensive Cancer Center) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Endometrial cancer (EC) remains the most common malignancy of the genital tract among women in developed countries. Although much research has been performed at genomic, transcriptomic and proteomic level, there is still a significant gap in the metabolomic studies of EC. [...]
2017 - 10.1038/s41598-017-09169-2
Scientific reports, Vol. 7 (august 2017)
|
|
|
9.
|
|
20 p, 2.0 MB |
Prognostic Biomarkers in Endometrial Cancer : A Systematic Review and Meta-Analysis
/
Coll de la Rubia, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martinez-Garcia, Elena (Quantitative Biology Unit, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg; (E.M.-G.); (G.D.)) ;
Dittmar, Gunnar (Quantitative Biology Unit, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg; (E.M.-G.); (G.D.)) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Endometrial cancer (EC) is the sixth most common cancer in women worldwide and its mortality is directly associated with the presence of poor prognostic factors driving tumor recurrence. Stratification systems are based on few molecular, and mostly clinical and pathological parameters, but these systems remain inaccurate. [...]
2020 - 10.3390/jcm9061900
Journal of clinical medicine, Vol. 9 (june 2020)
|
|
|
10.
|
|
16 p, 3.4 MB |
Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer
/
Casas-Arozamena, Carlos (Instituto de Investigación Sanitaria de Santiago (IDIS)) ;
Diaz, Eva (Foundation MD Anderson International (Madrid)) ;
Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Alonso-Alconada, Lorena (Nasasbiotech (La Coruña)) ;
Ferreiros, Alba (Nasasbiotech (La Coruña)) ;
Abalo, Alicia (Instituto de Investigación Sanitaria de Santiago (IDIS)) ;
López Gil, Carlos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Oltra, Sara S. (Foundation MD Anderson International (Madrid)) ;
de Santiago, Javier (Department of Gynecology, MD Anderson Cancer Center, 28029 Madrid, Spain) ;
Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sampayo, Victoria (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Bouso, Marta (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Arias, Efigenia (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Cueva, Juan (Instituto de Investigación Sanitaria de Santiago (IDIS)) ;
Colás Ortega, Eva (Centro de Investigación Biomédica en Red de Cáncer) ;
Vilar, Ana (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Gil-Moreno, Antonio 1965- (Centro de Investigación Biomédica en Red de Cáncer) ;
Abal Posada, Miguel (Centro de Investigación Biomédica en Red de Cáncer) ;
Moreno-Bueno, Gema (University of Madrid) ;
Muinelo-Romay, Laura (Centro de Investigación Biomédica en Red de Cáncer) ;
Universitat Autònoma de Barcelona
The incidence and mortality of endometrial cancer (EC) have risen in recent years, hence more precise management is needed. Therefore, we combined different types of liquid biopsies to better characterize the genetic landscape of EC in a non-invasive and dynamic manner. [...]
2020 - 10.3390/jcm9020585
Journal of clinical medicine, Vol. 9 (february 2020)
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
